CMR Surgical

CMR Surgical: Galaxy Care Becomes First Hospital in the World to Acquire the Versius Surgical Robotic System

Retrieved on: 
Wednesday, October 16, 2019
Hospitals, Health, Surgery, Medical devices, Medicine, Clinical medicine, Computer-assisted surgery, Telemedicine, CMR Surgical, Robot-assisted surgery, Laparoscopy, Surgery, Sandeep Nayak, Vipul Patel, the Galaxy Care Hospital, Pune, India, the Clinical Registry, the Versius® Surgical Robotic System, CMR Surgical Limited

CMR Surgical Ltd today announced that Galaxy Care Hospital in Pune, India, has become the first hospital in the world to procure Versius, a next-generation surgical robotic system.

Key Points: 
  • CMR Surgical Ltd today announced that Galaxy Care Hospital in Pune, India, has become the first hospital in the world to procure Versius, a next-generation surgical robotic system.
  • About the Galaxy Care Hospital, Pune, India
    Galaxy Care Hospital located in Pune, India is a specialist centre in laparoscopic and Robotic cancer surgeries.
  • The clinical registry established by CMR Surgical, working in partnership with customers will support post-market surveillance for the Versius Surgical Robotic System.
  • CMR Surgical is a British private limited company developing the next-generation universal robotic system, Versius, for minimal access surgery.

CMR Surgical raises £195 million ($240 million) in Series C financing

Retrieved on: 
Tuesday, September 17, 2019
Primary dealers, Subprime mortgage crisis, Finance, Economy of New York City, Financial services, CMR Surgical, Computer-assisted surgery, Telemedicine, Citigroup, Morgan Stanley, Robot-assisted surgery, Surgery

Cambridge, UK, 07:00 BST, 17 September 2019: CMR Surgical Limited, the Company developing, manufacturing and marketing the next-generation surgical robotic system, Versius, today announces that it has raised 195 million ($240 million) to fully fund the global commercialisation of the business.

Key Points: 
  • Cambridge, UK, 07:00 BST, 17 September 2019: CMR Surgical Limited, the Company developing, manufacturing and marketing the next-generation surgical robotic system, Versius, today announces that it has raised 195 million ($240 million) to fully fund the global commercialisation of the business.
  • CMR Surgical is expected to launch in hospitals across Europe and Asia imminently with further international expansion expected thereafter.
  • Umur Hursever, Partner, LGT Lightstone, commented: CMR Surgical has significant potential to make a real impact on the surgical robotics market.
  • The Series C financing was supported by Citigroup Global Markets Limited (Citi) and Morgan Stanley & Co. International plc (Morgan Stanley) as the Companys placement agents and joint financial advisors.

CIC participates in CMR Surgical’s £195 million ($240 million) Series C financing

Retrieved on: 
Tuesday, September 17, 2019
CMR Surgical, Medical technology, Robot-assisted surgery, Medicine, CMR, Surgery, Health

Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, has participated in the 195 million ($240 million) Series C funding round raised by CMR Surgical, the Cambridge-based company developing, manufacturing and marketing the next-generation surgical robotic system, Versius.

Key Points: 
  • Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, has participated in the 195 million ($240 million) Series C funding round raised by CMR Surgical, the Cambridge-based company developing, manufacturing and marketing the next-generation surgical robotic system, Versius.
  • CIC was an early investor in CMR Surgical having first invested in the companys Series A round in 2016.
  • CMR Surgical is expected to launch in hospitals across Europe and Asia imminently with further international expansion expected thereafter.
  • CMR Surgical is a British private limited company developing the next-generation universal robotic system, Versius, for minimal access surgery.

CMR Surgical raises £195 million ($240 million) in Series C financing

Retrieved on: 
Tuesday, September 17, 2019
Primary dealers, Subprime mortgage crisis, Finance, Economy of New York City, Financial services, CMR Surgical, Computer-assisted surgery, Telemedicine, Citigroup, Morgan Stanley, Robot-assisted surgery, Surgery

Cambridge, UK, 07:00 BST, 17 September 2019: CMR Surgical Limited, the Company developing, manufacturing and marketing the next-generation surgical robotic system, Versius, today announces that it has raised 195 million ($240 million) to fully fund the global commercialisation of the business.

Key Points: 
  • Cambridge, UK, 07:00 BST, 17 September 2019: CMR Surgical Limited, the Company developing, manufacturing and marketing the next-generation surgical robotic system, Versius, today announces that it has raised 195 million ($240 million) to fully fund the global commercialisation of the business.
  • CMR Surgical is expected to launch in hospitals across Europe and Asia imminently with further international expansion expected thereafter.
  • Umur Hursever, Partner, LGT Lightstone, commented: CMR Surgical has significant potential to make a real impact on the surgical robotics market.
  • The Series C financing was supported by Citigroup Global Markets Limited (Citi) and Morgan Stanley & Co. International plc (Morgan Stanley) as the Companys placement agents and joint financial advisors.

CIC participates in CMR Surgical’s £195 million ($240 million) Series C financing

Retrieved on: 
Tuesday, September 17, 2019
CMR Surgical, Medical technology, Robot-assisted surgery, Medicine, CMR, Surgery, Health

Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, has participated in the 195 million ($240 million) Series C funding round raised by CMR Surgical, the Cambridge-based company developing, manufacturing and marketing the next-generation surgical robotic system, Versius.

Key Points: 
  • Cambridge Innovation Capital (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, has participated in the 195 million ($240 million) Series C funding round raised by CMR Surgical, the Cambridge-based company developing, manufacturing and marketing the next-generation surgical robotic system, Versius.
  • CIC was an early investor in CMR Surgical having first invested in the companys Series A round in 2016.
  • CMR Surgical is expected to launch in hospitals across Europe and Asia imminently with further international expansion expected thereafter.
  • CMR Surgical is a British private limited company developing the next-generation universal robotic system, Versius, for minimal access surgery.